NYSE - Delayed Quote • USD
Agilent Technologies, Inc. (A)
At close: April 19 at 4:00 PM EDT
After hours: April 19 at 6:00 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Apr 2024) | Next Qtr. (Jul 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 15 | 14 | 19 | 19 |
| Avg. Estimate | 1.19 | 1.45 | 5.5 | 6.08 |
| Low Estimate | 1.17 | 1.38 | 5.45 | 5.75 |
| High Estimate | 1.2 | 1.49 | 5.55 | 6.33 |
| Year Ago EPS | 1.27 | 1.43 | 5.44 | 5.5 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Apr 2024) | Next Qtr. (Jul 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 14 | 13 | 19 | 19 |
| Avg. Estimate | 1.58B | 1.72B | 6.78B | 7.21B |
| Low Estimate | 1.57B | 1.67B | 6.72B | 7.01B |
| High Estimate | 1.59B | 1.74B | 6.99B | 7.43B |
| Year Ago Sales | -- | -- | 6.83B | 6.78B |
| Sales Growth (year/est) | -- | -- | -0.80% | 6.50% |
Earnings History
| CURRENCY IN USD | 4/30/2023 | 7/31/2023 | 10/31/2023 | 1/31/2024 |
|---|---|---|---|---|
| EPS Est. | 1.26 | 1.36 | 1.34 | 1.22 |
| EPS Actual | 1.27 | 1.43 | 1.38 | 1.29 |
| Difference | 0.01 | 0.07 | 0.04 | 0.07 |
| Surprise % | 0.80% | 5.10% | 3.00% | 5.70% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Apr 2024) | Next Qtr. (Jul 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 1.19 | 1.45 | 5.5 | 6.08 |
| 7 Days Ago | 1.19 | 1.45 | 5.5 | 6.09 |
| 30 Days Ago | 1.19 | 1.45 | 5.5 | 6.08 |
| 60 Days Ago | 1.27 | 1.43 | 5.49 | 6.07 |
| 90 Days Ago | 1.27 | 1.43 | 5.47 | 6.05 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Apr 2024) | Next Qtr. (Jul 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | 1 |
| Up Last 30 Days | 2 | 1 | 1 | 3 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | 1 | -- | -- | 2 |
Growth Estimates
| CURRENCY IN USD | A | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -6.30% | -- | -- | 1.60% |
| Next Qtr. | 1.40% | -- | -- | 10.50% |
| Current Year | 1.10% | -- | -- | 5.20% |
| Next Year | 10.50% | -- | -- | 13.30% |
| Next 5 Years (per annum) | 8.05% | -- | -- | 11.22% |
| Past 5 Years (per annum) | 16.19% | -- | -- | -- |
Research Analysis
Analyst Price Targets
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Analyst Recommendations
- Strong Buy
- Buy
- Hold
- Underperform
- Sell
Earnings
Upgrades & Downgrades
| Maintains | Barclays: Underweight to Underweight | 4/10/2024 |
| Upgrade | Stifel: Hold to Buy | 4/5/2024 |
| Maintains | Evercore ISI Group: In-Line to In-Line | 4/4/2024 |
| Maintains | Oppenheimer: Outperform to Outperform | 3/26/2024 |
| Maintains | Citigroup: Neutral to Neutral | 2/28/2024 |
| Maintains | UBS: Neutral to Neutral | 2/28/2024 |
Related Tickers
WAT Waters Corporation
296.10
+0.64%
DHR Danaher Corporation
235.51
-0.36%
TMO Thermo Fisher Scientific Inc.
544.78
+0.60%
MTD Mettler-Toledo International Inc.
1,188.54
-0.34%
IQV IQVIA Holdings Inc.
228.09
+0.40%
ILMN Illumina, Inc.
117.43
+0.63%
RVTY Revvity, Inc.
100.86
+1.49%
ICLR ICON Public Limited Company
288.23
-1.23%
IDXX IDEXX Laboratories, Inc.
476.35
-0.30%
CRL Charles River Laboratories International, Inc.
226.78
-0.34%